Full-Time

Automation Engineer

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Develops and commercializes biopharmaceuticals and vaccines

No salary listed

Senior

Dublin, Ireland

Category
Robotics and Automation Engineering
Mechanical Engineering
Required Skills
Data Analysis
Requirements
  • Degree in engineering (automation, robotics, computer science, etc.) or equivalent.
  • Minimum 5 years of work experience in GMP manufacturing, with expertise in automation.
  • Proficiency in automation solutions (Siemens, Omron, Mitsubishi, etc.).
  • Knowledge of industry standards (GAMP, ANSI/ISA, 21 CFR Part 11, Annex 11) and GxP/QA.
  • Strong problem-solving and analytical skills, with experience in data analysis.
  • Ability to work in a team-based culture, engaging with internal and external stakeholders.
  • Fluent in written and spoken English.
Responsibilities
  • Oversee automation systems to ensure maximum uptime and performance.
  • Manage system user access, backups, and restores.
  • Implement corrective actions and collaborate with vendor technical support.
  • Identify and execute small projects to enhance system performance.
  • Contribute to capital planning, project execution, and documentation.
  • Ensure all activities comply with site and corporate Quality Systems.
  • Create and maintain engineering deliverables and test scripts.
  • Develop and implement global automation strategies to standardize processes.
  • Maintain and optimize automation systems and infrastructure.
  • Develop solutions tailored to the manufacturing environment.
  • Drive automation projects, ensuring cost, schedule, and technical goals are met.
  • Stay updated with technology trends and benchmarks to keep Takeda at the forefront.
Desired Qualifications
  • Experience in the pharmaceutical industry is advantageous.
  • Familiarity with ANSI/ISA-99,100 standards is a plus.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized and environmental risks are managed.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene is worth up to $770 million.
  • The company is expanding its market presence in emerging Asian economies.
  • Takeda's focus on personalized medicine aligns with industry trends.

What critics are saying

  • Antitrust litigation over Amitiza could harm Takeda's reputation and finances.
  • A data breach incident poses significant cybersecurity and legal risks.
  • The telehealth market's rapid changes may affect Takeda's investment in American Well.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations.
  • Takeda has a robust pipeline with 11 NMEs and aims for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

ETF Daily News
May 11th, 2025
Tudor Investment Corp ET AL Decreases Stock Holdings in American Well Co. (NYSE:AMWL)

Takeda Pharmaceutical Co. Ltd. acquired a new stake in American Well in the fourth quarter worth about $564,000.

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.